Reaction
Adenocarcinoma Pancreas reporting signals
As of the last recalculation, Adenocarcinoma Pancreas appears in 1,271 FAERS reports alongside 28 co-occurring drug terms. The strongest observed disproportionality signal is SITAGLIPTIN AND METFORMIN HYDROCHLORIDE (PRR 85.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Sitagliptin And Metformin Hydrochloride | 104 | 85.9 | 86.3 |
| Sitagliptin | 250 | 70.5 | 70.7 |
| Exenatide | 157 | 55.6 | 55.8 |
| Liraglutide | 117 | 42.6 | 42.7 |
| Gemcitabine | 89 | 39.7 | 39.8 |
| Gemcitabine Hydrochloride | 98 | 32.7 | 32.7 |
| Pancrelipase | 61 | 27.1 | 27.2 |
| Ezetimibe And Simvastatin | 15 | 16.3 | 16.4 |
| Thiotepa | 9 | 15.5 | 15.6 |
| Captopril | 9 | 15.4 | 15.4 |
| Busulfan | 13 | 13.7 | 13.7 |
| Pioglitazone | 35 | 13.6 | 13.6 |
| Nevirapine | 7 | 12.8 | 12.8 |
| Insulin Aspart | 46 | 11.8 | 11.8 |
| Paclitaxel | 66 | 11.5 | 11.5 |
| Glimepiride | 25 | 10.7 | 10.7 |
| Sevoflurane | 5 | 9.9 | 9.9 |
| Glipizide | 35 | 9.6 | 9.7 |
| Insulin Glulisine | 5 | 8.1 | 8.1 |
| Oxaliplatin | 35 | 7.9 | 7.9 |
| Fluorouracil Cream, 0.5% | 34 | 7.5 | 7.5 |
| Fluorouracil | 34 | 7.4 | 7.4 |
| Insulin Glargine | 102 | 7.3 | 7.3 |
| Oral Semaglutide | 31 | 7.1 | 7.1 |
| Vemurafenib | 5 | 6.8 | 6.8 |
| Irinotecan Hydrochloride | 5 | 6.4 | 6.4 |
| Siponimod | 3 | 5.5 | 5.5 |
| Dulaglutide | 22 | 4.1 | 4.1 |